Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Gross

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Hepatology (Baltimore, Md.)|September 4, 2010
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosisPradyumna Phatak, Pierre Brissot, Mark Wurster, et al.
Journal of Neurosurgery. Spine|July 11, 2025
Long-term functional outcomes and their relationship to nerve root sacrifice after definitive surgery for sacrococcygeal chordomaYuanxuan Xia, Pritika Papali, Abdel-Hameed Al-Mistarehi, et al.
The American Journal of Surgical Pathology|June 3, 2026
Clinical Outcomes and Prognostication of CRTC1::TRIM11 Fusion Cutaneous TumorsNithya S Trichy, Jonathan Braat, Lindsay J Holic, et al.
Neurosurgery|August 5, 2024
Outcomes After Definitive Surgery for Spinal and Sacral Chordoma in 101 Patients Over 20 YearsYuanxuan Xia, Pritika Papali, Abdel-Hameed Al-Mistarehi, et al.
Neurosurgery|February 27, 2026
Clinical Outcomes Following Surgical Resection for Patients With Malignant Peripheral Nerve Sheath TumorsMelanie Alfonzo Horowitz, Jawad M Khalifeh, Xinlan Yang, et al.
The American Journal of Surgical Pathology|October 2, 2025
PRRX1 -rearranged Fibroblastic Tumors : A Clinicopathologic and Molecular Study of 18 Cases Including a Novel PRRX1::EP300 FusionCarina A Dehner, Jorge Torres-Mora, Judith Jebastin Thangaiah, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 10, 2025
Malignant Chondroblastoma: An Epigenetically Distinct Subtype of Chondroblastoma With a Predilection for the Skeletally MatureKaren Fritchie, Baptiste Ameline, Vanghelita Andrei, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|May 20, 2025
Clarifying the role of the resist-accept-direct framework in supporting resource management planning processesGregor W Schuurman, Wylie Carr, Cat Hawkins Hoffman, et al.
Brain Pathology (Zurich, Switzerland)|March 25, 2024
NAB2::STAT6 fusions and genome-wide DNA methylation profiling: Predictors of patient outcomes in meningeal solitary fibrous tumorsKathryn L Eschbacher, Quynh T Tran, Evgeny A Moskalev, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 30, 2020
Interpretable multimodal deep learning for real-time pan-tissue pan-disease pathology search on social mediaAndrew J Schaumberg, Wendy C Juarez-Nicanor, Sarah J Choudhury, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Hepatology (Baltimore, Md.)|September 4, 2010
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosisPradyumna Phatak, Pierre Brissot, Mark Wurster, et al.
Journal of Neurosurgery. Spine|July 11, 2025
Long-term functional outcomes and their relationship to nerve root sacrifice after definitive surgery for sacrococcygeal chordomaYuanxuan Xia, Pritika Papali, Abdel-Hameed Al-Mistarehi, et al.
The American Journal of Surgical Pathology|June 3, 2026
Clinical Outcomes and Prognostication of CRTC1::TRIM11 Fusion Cutaneous TumorsNithya S Trichy, Jonathan Braat, Lindsay J Holic, et al.
Neurosurgery|August 5, 2024
Outcomes After Definitive Surgery for Spinal and Sacral Chordoma in 101 Patients Over 20 YearsYuanxuan Xia, Pritika Papali, Abdel-Hameed Al-Mistarehi, et al.
Neurosurgery|February 27, 2026
Clinical Outcomes Following Surgical Resection for Patients With Malignant Peripheral Nerve Sheath TumorsMelanie Alfonzo Horowitz, Jawad M Khalifeh, Xinlan Yang, et al.
The American Journal of Surgical Pathology|October 2, 2025
PRRX1 -rearranged Fibroblastic Tumors : A Clinicopathologic and Molecular Study of 18 Cases Including a Novel PRRX1::EP300 FusionCarina A Dehner, Jorge Torres-Mora, Judith Jebastin Thangaiah, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 10, 2025
Malignant Chondroblastoma: An Epigenetically Distinct Subtype of Chondroblastoma With a Predilection for the Skeletally MatureKaren Fritchie, Baptiste Ameline, Vanghelita Andrei, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|May 20, 2025
Clarifying the role of the resist-accept-direct framework in supporting resource management planning processesGregor W Schuurman, Wylie Carr, Cat Hawkins Hoffman, et al.
Brain Pathology (Zurich, Switzerland)|March 25, 2024
NAB2::STAT6 fusions and genome-wide DNA methylation profiling: Predictors of patient outcomes in meningeal solitary fibrous tumorsKathryn L Eschbacher, Quynh T Tran, Evgeny A Moskalev, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 30, 2020
Interpretable multimodal deep learning for real-time pan-tissue pan-disease pathology search on social mediaAndrew J Schaumberg, Wendy C Juarez-Nicanor, Sarah J Choudhury, et al.
Pageof 5